Nootropics Index - Save on smarter supplements
Botanical & herbal supplements

Kava

Piper methysticum root extract

Kava is a Piper methysticum root preparation studied for calm and anxiety-related symptoms, with mixed trial results. Compare kavalactone content and preparation type, not just root or extract weight. Rare serious liver injury and sedative combinations are important cautions.

Standardized ExtractMixed EvidencePopulation Specific EvidenceSedation RiskLiver CautionMedication Interaction RiskAlcohol Interaction Risk
Updated October 2026/6 min read/8 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
Extra caution

Who should avoid this or get expert review first

This is not a recommendation to use. These groups should treat the profile as a reason to slow down and verify safety, rules, and personal context.

  • Pregnancy and breastfeeding1Avoid kava during pregnancy or breastfeeding because safety concerns extend beyond ordinary adult use.
  • Liver conditions or a previous reaction4People with liver disease or a previous suspected kava liver reaction should seek clinical advice rather than retrying it.
01

What is it?

A favorable shorter trial

2

A six-week study enrolled 75 adults with generalized anxiety disorder and analyzed 58 after a placebo run-in. Anxiety scores favored a specific water-extracted kava preparation, with a moderate standardized difference. Headaches were more frequent, while liver tests did not differ. This was a selected clinical population, not a general nootropic study.

The larger study did not confirm the benefit

3

In 171 unmedicated adults with the same diagnosis, a 16-week aqueous-root-extract trial found no significant anxiety-score advantage over placebo. Reports of poorer memory, shakiness and abnormal liver tests were more frequent, although nobody met the trial criteria for herb-induced liver injury.

02

Names, aliases and forms

Latin NamePiper methysticum
Common NameKava-kava
Active ConstituentKavalactones
03

Potential effects and evidence map

Human anxiety research is mixed, and evidence for general cognitive enhancement is insufficient. A favorable shorter trial was not confirmed by a larger 16-week trial. These clinical findings do not establish reliable everyday relaxation or performance benefits in healthy users.

Effect domainMagnitudeGrade
Calm / relaxation1
CumulativeConfidence: Medium

Some trials report lower anxiety scores, but findings conflict and do not establish a dependable healthy-user relaxation effect.

Note Clinical anxiety outcomes are not cognitive enhancement.

2/5
B
04

Typical dosages and timing

Studied kavalactones2120-240 mg/day

The shorter clinical trial used this daily kavalactone range in an aqueous extract, with an increase based on response. These are constituent amounts, not milligrams of root powder. The protocol is research context, not a recommended serving or a guarantee of safety.

05

Timing & effect horizon

Effect horizonCumulative
Cumulative
Study window3Cumulative
16 weeks
A course length is not an effect duration3

The study window shown here belongs to the larger negative trial. It does not establish onset, how long one dose feels active, or an effective cycling schedule. A single The time for blood levels to fall by half during the final elimination phase.Source for a mixed kavalactone preparation would also be misleading without preparation-specific data.

06

Safety, side effects and risk profile

Why the base rating is moderate4
For oral root extracts around the studied constituent amounts over weeks, low would understate the rare possibility of clinically important liver injury, not merely stomach upset. Severe cases can be irreversible even though many users tolerate kava. Moderate is a severity-and-likelihood judgment, not a claim that injury is common; preparation-specific rates remain uncertain.
Liver / kidney caution4
Confidence: High

Rare acute liver injury has occurred with kava products, including severe or fatal cases.

Note Moderate weighs uncommon occurrence against potentially severe injury; the incidence and role of preparation, susceptibility and co-exposures remain uncertain.

3/5
B
Sedation / impairment1
Confidence: Medium

Dizziness and sedative effects can matter for driving or coordination; avoid hazardous tasks when affected.

Note This is not a claim that every studied dose impairs cognition.

2/5
B
Interaction risk1
Confidence: High

Do not combine kava with alcohol or other sedatives; medication combinations need professional review.

Note Combination-product risks are separate from single-ingredient exposure.

3/5
B
Water extraction is not a safety certificate1

Liver-injury reports initially involved alcohol- or acetone-extracted products, but cases have also involved water-prepared beverages. Cultivar, plant part, contamination, co-use and individual susceptibility may contribute; a noble or water-extracted label cannot rule the risk out.

07

Interactions and cautions

Alcohol and sedatives1

Alcohol, benzodiazepines and other sedatives can compound kava effects. Review medicines with a pharmacist or clinician instead of assuming that a botanical product has no interactions.

Kava plus kratom is a different exposure5

A 2026 CDC analysis found increasing poison-center reports involving kava and kratom together, alongside more serious reported outcomes. These selected reports have no population-use denominator and cannot give the risk rate for ordinary single-ingredient kava. Check combination-drink ingredients carefully.

09

How it compares

Root powder, aqueous extract and blends5

Traditional water preparations, concentrated tablets and ready-to-drink mixtures can differ in plant material, extraction and constituent concentration. Equal product weights are not equivalent exposures. A multi-botanical drink should not inherit the evidence for a specified kava-only trial extract.

10

Practical buying and quality notes

  • Look for Piper methysticum identity, plant part, extraction method, actual kavalactone content and batch testing. Cultivar and root-only claims are useful traceability details, not proof against liver injury. No linked offers are currently available for a product-by-product comparison.1
  • Arithmetic example, not a serving recommendation: 200 mg of extract standardized to 30% kavalactones contains 60 mg kavalactones. A 60-capsule bottle at that strength contains 3.6 g of declared kavalactones; divide its price by 3.6 for cost per gram. Do not apply this conversion to an unstandardized powder or a blend with undisclosed amounts.
11

FAQ

What dose of kava was studied?

2

The dosage row reports kavalactone amounts in a specified water extract. Total root or extract weight alone cannot reproduce that exposure, and an effective general relaxation dose has not been established by the conflicting trials.

How long does kava last, and should it be cycled?

3

These repeated-use trials do not define a reliable single-dose duration or an evidence-based on/off cycle. A longer study period is not evidence that longer use is beneficial or safer.

12

References

  1. NCCIH. Kava: usefulness and safety. Updated April 2025; accessed 2026-10-12.
  2. Sarris J et al. Kava in generalized anxiety disorder: a double-blind randomized placebo-controlled study. J Clin Psychopharmacol. 2013;33:643-648.
  3. Sarris J et al. Kava for generalised anxiety disorder: a 16-week double-blind randomised placebo-controlled study. Aust N Z J Psychiatry. 2020;54:288-297.
  4. NIDDK. Kava Kava. LiverTox. Updated 2018; accessed 2026-10-12.
  5. Towers EB et al. Poison-center reports linked to kratom-containing kava products, United States, 2000-2025. MMWR. 2026;75:157-163.
  6. California Department of Public Health. Consumer Facts: Kava. Accessed 2026-10-12.
  7. UK Government / Food Standards Agency. Importing herbs and spices: kava-kava import ban. Accessed 2026-10-12.
  8. MHRA. Banned and restricted herbal ingredients: Kava-kava Prohibition Order 2002. Accessed 2026-10-12.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.